Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community-acquired respiratory tract infections?

被引：0
|
作者：
Anna Marchese
Susanna Esposito
Ramona Barbieri
Matteo Bassetti
Eugenio Debbia
机构：
[1] University of Genoa,Microbiology Unit, DISC Department
[2] University of Milan,Department of Maternal and Pediatric Sciences
[3] Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico,Infectious Diseases Division
[4] S. Maria della Misericordia University Hospital,undefined
来源：
BMC Infectious Diseases | / 12卷
关键词：
CLSI; Interpretive criteria; Resistance; Antibiotics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] PENICILLINS AND MACROLIDES IN THE TREATMENT OF COMMUNITY-ACQUIRED RESPIRATORY-TRACT INFECTIONS
    KERNBAUM, S
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1987, 6 (03) : 328 - 331
  • [42] The safety of azithromycin in the treatment of adults with community-acquired respiratory tract infections
    Treadway, G
    Pontani, D
    Reisman, A
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 19 (03) : 189 - 194
  • [43] Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010
    Wang, Hui
    Chen, Minjun
    Xu, Yingchun
    Sun, Hongli
    Yang, Qiwen
    Hu, Yunjian
    Cao, Bin
    Chu, Yunzhuo
    Liu, Yong
    Zhang, Rong
    Yu, Yunsong
    Sun, Ziyong
    Zhuo, Chao
    Ni, Yuxing
    Hu, Bijie
    Tan, Thean Yen
    Hsueh, Po-Ren
    Wang, Jen-Hsien
    Ko, Wen-Chien
    Chen, Yen-Hsu
    Wahjono, Hendro
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 38 (05) : 376 - 383
  • [44] Resistant Haemophilus influenzae in community-acquired respiratory tract infections:: a role for cefixime
    Verhoef, J
    Gillissen, A
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 21 (06) : 501 - 509
  • [45] Telithromycin - A ketolide antibiotic for the treatment of outpatients with community-acquired respiratory tract infections
    Counts, M
    CLINICAL NURSE SPECIALIST, 2005, 19 (03) : 121 - 123
  • [46] Therapeutic implications of antibacterial resistance in community-acquired respiratory tract infections in children
    Cunha, BA
    INFECTION, 2004, 32 (02) : 98 - 108
  • [47] A Pooled Analysis of Telithromycin in the Treatment of Community-Acquired Respiratory Tract Infections in Adults
    C. Carbon
    Infection, 2003, 31 : 308 - 317
  • [48] Population pharmacokinetics and pharmacodynamics of garenoxacin in patients with community-acquired respiratory tract infections
    Van Wart, S
    Phillips, L
    Ludwig, EA
    Russo, R
    Gajjar, DA
    Bello, A
    Ambrose, PG
    Costanzo, C
    Grasela, TH
    Echols, R
    Grasela, DM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) : 4766 - 4777
  • [49] Telithromycin: The first ketolide antibacterial for the treatment of community-acquired respiratory tract infections
    Lorenz, J
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2003, 57 (06) : 519 - 529
  • [50] Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of community-acquired respiratory tract infections
    Calbo, E
    Garau, J
    RESPIRATION, 2005, 72 (06) : 561 - 571
12345